UofL’s Bolli gets $12.8M NIH grant for stem cell research

Published on September 9, 2011

Dr. Roberto Bolli, a researcher at the University of Louisville, has been awarded a $12.8 million grant renewal from the National Institutes of Health for adult stem cell research.

Bolli’s project, originally funded in 2006 with an $11.7 million grant, involves research in four areas, according to a news release. They are:

  • Investigating how introducing genes into stem cells might improve stem cell therapies;
  • Looking at how diabetes affects stem cells;
  • Looking at how a class of proteins, called cytokines, affects stem cells during heart failure;
  • Investigating the signaling pathways of stem cells in the body.

“UofL has a mandate to become a nationally recognized metropolitan research university. One gauge is our faculty’s ability to attract competitive grant funding from the NIH,” UofL President James R. Ramsey said in the release. “The fact that our program has been renewed during these very competitive times demonstrates yet again the high quality talent we have at UofL. Even more importantly, our faculty are turning research discoveries into medical treatments that enhance the lives of their patients.”

Bolli and his team have brought to UofL more than $100 million in NIH grants since his arrival in Louisville in 1994.

As Business First reported last month, UofL had the fourth-largest increase in federal science and engineering research funding between 1999 and 2009, according to the Chronicle of Higher Education. UofL jumped from $20 million to $72.8 million in federally funded research during that decade, a 263 percent increase.